Clinuvel Pharmaceuticals Ltd (OTC Pink - Current Information:CLVLY)

Data as of 10:58am ET
 +0.01 / +0.34%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

Clinuvel Pharmaceuticals Ltd. operates as a global biopharmaceutical company. It is focused on the development of SCENESSE, its proprietary photoprotective drug. The company also focuses on developing drugs for the treatment of severe skin disorders. Clinuvel Pharmaceuticals was founded on December 14, 1999 and is headquartered in Melbourne, Australia.

Contact Information

Clinuvel Pharmaceuticals Ltd.
190 Queen Street
Melbourne Victoria (vic) 3000
P:(139) 660-4900
Investor Relations:



Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Philippe J. WolgenChief Executive Officer, Director & MD
Darren M. KeamyChief Financial Officer & Secretary
Dennis J. WrightChief Scientific Officer
Lachlan HayMedia Relations

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.